Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (68 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, Aledex, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revyve are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.


TSXV:KNE - Post by User

Bullboard Posts
Comment by knollon Apr 06, 2013 2:01pm
202 Views
Post# 21220869

RE: MOVING FORWARD

RE: MOVING FORWARD

Yes revenues is what Kane needs now not news. The Venture Exchange has been in a two year consolidation. It has gone from 2400 to a low 1017 this week. That's about 65% down. 80% of the companies here has a similar chart to match the Ventures. Note: as well, the major exchanges has hit new highs. It doesn't matter what Kane puts out they will be sucked into this black hole regardless. The day traders will need to be a little more patient as the rest of us. Money will comeback to the Venture, it always does. It may take another quarter but the Venture is showing higher lows.

I see Kane as doing really well concidering. StrixNB  is going to be big. I am surprised how meny people I know who has heard of this. They are going slowly where the news is preceeding the product. By the time it reaches Ontario and Quebec it would be well antisipated/recieved.

Bullboard Posts